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Effect of Dietary Peptidoglycan on Growth Performance of Chronic
Antigen Exposed Pigs
Abstract
The effect of an orally active immune modulator on growth and feed utilization in chronic antigen-challenged
pigs was evaluated. In each of 16 litters, four pigs were allotted from each litter to one of four dietary
concentrations (0, 22, 44, or 66 ppm) of peptidoglycan derived from Bifidobacterium thermophilum. The pigs
were derived from a single herd, weaned at 10 to 16 days of age, placed in nonsanitized nursery, and orally
exposed to excreta of older pigs in the base herd at 4-day intervals from 9 to 76 lb body weight. Pigs were
individually penned and allowed to consume feed and water ad libitum. Daily gains and feed/gain ratios of
pigs were not altered by dietary peptidoglycan concentrations. Based on these data, dietary additions of
peptidoglycan did not enhance the growth performance of chronic antigen-exposed pigs.
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Summary and Implications
The effect of an orally active immune modulator on
growth and feed utilization in chronic antigen-challenged
pigs was evaluated. In each of 16 litters, four pigs were
allotted from each litter to one of four dietary concentrations
(0, 22, 44, or 66 ppm) of peptidoglycan derived from
Bifidobacterium thermophilum. The pigs were derived from
a single herd, weaned at 10 to 16 days of age, placed in
nonsanitized nursery, and orally exposed to excreta of older
pigs in the base herd at 4-day intervals from 9 to 76 lb body
weight. Pigs were individually penned and allowed to
consume feed and water ad libitum. Daily gains and
feed/gain ratios of pigs were not altered by dietary
peptidoglycan concentrations. Based on these data, dietary
additions of peptidoglycan did not enhance the growth
performance of chronic antigen-exposed pigs.
Introduction
Antigen exposure in pigs and the immune system
response that follows result in economic losses in the pig
industry. The immune system functions to eliminate
antigens from the pig. The immune system will remain
chronically active if the antigen is not completely eliminated
or if the animal is continually reinfected. The immune
response involves the release of cytokines, a class of pro-
inflammatory compounds. Cytokines act on the animalÕs
physiological capacity for growth by reducing feed intake
and reducing anabolic hormone secretion, which results in
slower accretion rates of proteinaceous body tissues and less
efficient utilization of feed for growth. Enhancing the
effectiveness of the immune system to rapidly eliminate
antigens should enable pigs to grow faster and use feed more
efficiently.
Preliminary evidence suggests that peptidoglycan from
Bifidobacterium thermophilum may be an efficacious
immune modulator in animals. Ingestion of peptidoglycan
by pigs during the first five days post-farrowing enhances
antibody production by immune cells in the small intestinal
wall (1,2). Peptidoglycan ingestion also increases the
cytotoxic activity of natural killer cells following E. Coli
challenge and T cells in mice (3,4).
The purpose of this study was to determine the impact
of peptidoglycan feeding on body growth and efficiency of
feed utilization in chronic antigen exposed pigs.
Materials and Methods
Pigs from a single genetic strain and site of origin were
used. The herd of origin commonly possesses serological
titers for mycoplasma hyopneumonia (MP), actinobacillus
pleuropneumoniae (APP), porcine reproductive and
respiratory syndrome (PRRS), swine influenza virus (SIV),
and transmissible gastroenteritis (TGE). Pigs were weaned
at 12 days of age (range of 10 to 16 days of age) and placed
in an unsanitized nursery facility located at the site of origin
of the pigs. Pigs were individually penned in 1.5 x 4 ft pens
on tri-bar flooring. Ambient room temperature was
maintained at 88¼F at weaning and then lowered by 1.5¼F
every 4 days until 74¼F was achieved. Pigs were allowed to
consume a basal diet (Table 1) and water ad libitum from
weaning to 76 lb body weight. Pigs were exposed to excreta
from older pigs at four-day intervals throughout the duration
of the study. No antimicrobial agents (subtherapeutic or
therapeutic) were administered to the pigs during the study.
Table 1. Composition of basal diet.
Ingredient %
Corn 24.7
Soybean meal, dehulled 46.2
Whey, dried 20.0
Skim milk, dried 5.0
D, L-Methionine .25
Dicalcium phosphate 2.5
Limestone .31
Salt .25
Choline chloride .17
Vit & TM Mixa .48
Corn starch .15
aContributed the following per lb of diet: biotin, .05
mg; folacin, .81 mg; niacin, 40.9 mg; pantothenic
acid, 27.3 mg; riboflavin, 9.5 mg; pyridoxine, 1.4
mg; vitamin B12, .048 mg; vitamin A, 6000 IU;
vitamin E, 44 IU; vitamin D, 601 IU; vitamin K, 1.4
mg; Fe, 80 mg; Zn, 68.2 mg; Mn, 27.2 mg; Cu, 8.0
mg; I, .09 mg; Se, .11 mg.
Sixteen sets of four littermate pigs were used. Pigs were
allotted within litter to one of four dietary concentrations (0,
22, 44, or 66 ppm) of peptidoglycan (derived from
bifidobacterium thermophilum).
Pig weights and feed consumption were determined
every four days. One pig in each litter was bled at the
initiation and termination of the study for determination of
the pigÕs serological titers for prevalent antigens (MP, APP,
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PRRS, SIV, and TGE). Pigs also were bled at 16-day
intervals for quantification of the acute phase protein alpha-1-
glycoprotein as an indicator of the level of antigen exposure
the pigsÕ experienced during each stage of the study.
The data were analyzed as a randomized complete block
design using the General Linear Model of SAS (1997). The
pig was considered the experimental unit. Least square
means are reported.
Results and Discussion
As desired in the study, the experimental pigs
experienced a chronic antigen exposure during the study.
Daily gains and feed/gain ratios of pigs in the current study
were compatible with those of chronic antigen exposed pigs
evaluated in previous studies conducted at our station.
Dietary peptidoglycan concentrations of 22 to 66 ppm
did not alter the daily feed intake, daily weight gain, or
feed/gain ratios of pigs fed from weaning (9 lb) to 76 lb
body weight (Table 2).
Pigs weaned at 10 to 16 days of age initially possess
some passive immunity via the antibodies they initially
obtain from their damsÕ colostrum. Furthermore, the
animalsÕ ability to mount an immune response to an
antigen is not immediate but requires recognition and
processing of the antigen and subsequent synthesis of the
immune components. Thus, the responses of the pigs to
dietary peptidoglycan feeding at three different stages of
growth (9 to 27, 27 to 44, and 44 to 76 lb) were evaluated.
In each stage of growth, daily gain and feed ratios were not
altered by dietary peptidoglycan additions (Table 3).
Based on these data, orally administered peptidoglycan
(22 to 66 ppm in diet) is not an efficacious growth
promotant in chronic antigen-exposed pigs.
Table 2. Growth and feed utilization in antigen-
exposed pigs. I. Responses over the duration of
the study.a
Dietary peptidoglycan, ppm
Criteria 0 22 44 66
No. of pens 16 14 15 16
Pig weight, lb
Initial 9.3 9.3 9.1 9.4
Final 77.2 76.0 75.4 76.0
Growth and feed utilizationb
Daily gain,
lb
1.02 1.03 1.02 1.02
Daily feed,
lb
1.92 1.87 1.86 1.85
Feed/gain 1.89 1.82 1.83 1.83
aPigs were individually penned and allowed to
consume feed and water ad libitum.
bLeast square means reported.
Table 3. Growth and feed utilization in antigen
challenged pigs.  II. Responses during three
stages of growth.
Pig Dietary peptidoglycan, ppm
Criteria wt, lb 0 22 44 66
Daily gain,
lba,b
9-27 .53 .55 .55 .53
27-44 1.63 1.67 1.67 1.67
44-76 1.63 1.67 1.67 1.67
Feed/gaina,b 9-27 1.54 1.50 1.55 1.51
27-44 1.72 1.65 1.66 1.67
44-76 2.17 2.10 2.10 2.09
aDaily gains and feed/gain ratios of pigs fed from 9
to 27, 27 to 44, and 44 to 76 pounds. Raw means
reported.
bEffect of pig weight, P<.01.
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